A review: potential of resveratrol and its analogues to mitigate diseases via gut microbial modulation
)Abstract
The stilbenoids form a group of bioactive phenolic compounds found in various plant species whose original functions are to act as protective compounds against microbial infections and toxins. Among the stilbenoids, resveratrol is the most well-studied and has been shown to exert multiple benefits in disease prevention. The bioavailability of resveratrol is one of the major limitations in its role as a disease-prevention agent; however, it has exhibited biological activity in animals and clinical models. Gut microbiota may play a role in overcoming limited bioavailability via microbial transformations. On the other hand, the modulatory effects of stilbenoids on gut microbial dysbiosis induced by several diseases can be crucial in disease alleviation. In addition to gut microbial metabolites, such as SCFAs (short-chain fatty acids), stilbenoids can be used to inhibit microbial growth, making their use a potential strategy in preventing disease progression. In this review, the interactions of stilbenoids (with a major focus on resveratrol and pterostilbene) and gut microbiota will be discussed to clarify the importance of gut microbiota in the strategy of "disease prevention via phytochemicals."
References
Akinwumi, B.C., Bordun, K.-A.M., and Anderson, H.D. (2018). Biological Activities of Stilbenoids. Int. J. Mol. Sci. 19: 792.
Alrafas, H.R., Busbee, P.B., Nagarkatti, M., and Nagarkatti, P.S. (2019). Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells. J Leukoc Biol. 106: 467–480.
Bode, L.M., Bunzel, D., Huch, M., Cho, G.-S., Ruhland, D., Bunzel, M., Bub, A., Franz, C.M.A.P., and Kulling, S.E. (2013). In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr. 97: 295–309.
Carrera-Quintanar, L., López Roa, R.I., Quintero-Fabián, S., Sánchez-Sánchez, M.A., Vizmanos, B., and Ortuño-Sahagún, D. (2018). Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases. Mediators Inflamm. 2018: 9734845.
Chen, H.-E., Lin, Y.-J., Lin, I.C., Yu, H.-R., Sheen, J.-M., Tsai, C.-C., Huang, L.-T., and Tain, Y.-L. (2019). Resveratrol prevents combined prenatal NG-nitro-L-arginine-methyl ester (L-NAME) treatment plus postnatal high-fat diet induced programmed hypertension in adult rat offspring: interplay between nutrient-sensing signals, oxidative stress and gut microbiota. J. Nutr. Biochem. 70: 28–37.
Chen, M., Hou, P., Zhou, M., Ren, Q., Wang, X., Huang, L., Hui, S., Yi, L., and Mi, M. (2020). Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clin Nutr. 39: 1264–1275.
Chen, M.-L., Yi, L., Zhang, Y., Zhou, X., Ran, L., Yang, J., Zhu, J.-d., Zhang, Q.-y., and Mi, M.-t. (2016). Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio. 7: e02210–e02215.
Etxeberria, U., Arias, N., Boqué, N., Macarulla, M.T., Portillo, M.P., Martínez, J.A., and Milagro, F.I. (2015). Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J. Nutr. Biochem. 26: 651–660.
Etxeberria, U., Hijona, E., Aguirre, L., Milagro, F.I., Bujanda, L., Rimando, A.M., Martínez, J.A., and Portillo, M.P. (2017). Pterostilbene-induced changes in gut microbiota composition in relation to obesity. Mol. Nutr. Food Res. 61: 1500906.
Giuliani, C., Marzorati, M., Innocenti, M., Vilchez-Vargas, R., Vital, M., Pieper, D.H., Van de Wiele, T., and Mulinacci, N. (2016). Dietary supplement based on stilbenes: a focus on gut microbial metabolism by the in vitro simulator M-SHIME®. Food Funct. 7: 4564–4575.
Hijona, E., Aguirre, L., Pérez-Matute, P., Villanueva-Millán, M.J., Mosqueda-Solis, A., Hasnaoui, M., Nepveu, F., Senard, J.M., Bujanda, L., Aldámiz-Echevarría, L., Llarena, M., Andrade, F., Perio, P., Leboulanger, F., Hijona, L., Arbones-Mainar, J.M., Portillo, M.P., and Carpéné, C. (2016). Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects. J. Physiol. Biochem. 72: 567–582.
Hinderliter, P., and Saghir, S.A. (2014). Encyclopedia of Toxicology (Third Edition). Academic Press, Oxford, pp. 849–855.
Huang, Y.-C., Huang, L.-T., Sheen, J.-M., Hou, C.-Y., Yeh, Y.-T., Chiang, C.-P., Lin, I.C., Tiao, M.-M., Tsai, C.-C., Lin, Y.-J., Chen, C.-C., Tain, Y.-L., and Yu, H.-R. (2020). Resveratrol treatment improves the altered metabolism and related dysbiosis of gut programed by prenatal high-fat diet and postnatal high-fat diet exposure. J. Nutr. Biochem. 75: 108260.
Jaimes, J.D., Jarosova, V., Vesely, O., Mekadim, C., Mrazek, J., Marsik, P., Killer, J., Smejkal, K., Kloucek, P., and Havlik, J. (2019). Effect of Selected Stilbenoids on Human Fecal Microbiota. Molecules. 24: 744.
Jarosova, V., Vesely, O., Marsik, P., Jaimes, J.D., Smejkal, K., Kloucek, P., and Havlik, J. (2019). Metabolism of Stilbenoids by Human Faecal Microbiota. Molecules. 24: 1155.
Jeandet, P., Sobarzo-Sánchez, E., Silva, A.S., Clément, C., Nabavi, S.F., Battino, M., Rasekhian, M., Belwal, T., Habtemariam, S., Koffas, M., and Nabavi, S.M. (2020). Whole-cell biocatalytic, enzymatic and green chemistry methods for the production of resveratrol and its derivatives. Biotechnol. Adv. 39: 107461.
Koh, Y.-C., Li, S., Chen, P.-Y., Wu, J.-C., Kalyanam, N., Ho, C.-T., and Pan, M.-H. (2019). Prevention of Vascular Inflammation by Pterostilbene via Trimethylamine-N-Oxide Reduction and Mechanism of Microbiota Regulation. Mol. Nutr. Food Res. 63: 1900514.
Lee, W.X., Basri, D.F., and Ghazali, A.R. (2017). Bactericidal Effect of Pterostilbene Alone and in Combination with Gentamicin against Human Pathogenic Bacteria. Molecules. 22: 463.
Ma, Y., Liu, S., Shu, H., Crawford, J., Xing, Y., and Tao, F. (2020). Resveratrol alleviates temporomandibular joint inflammatory pain by recovering disturbed gut microbiota. Brain Behav. Immun. 87: 455–464.
Manning, T.S., and Gibson, G.R. (2004). Prebiotics. Best Pract Res Clin Gastroenterol. 18: 287–298.
Martel, J., Ojcius, D.M., Ko, Y.-F., and Young, J.D. (2020). Phytochemicals as Prebiotics and Biological Stress Inducers. Trends Biochem. Sci. 45: 462–471.
Mattio, L.M., Dallavalle, S., Musso, L., Filardi, R., Franzetti, L., Pellegrino, L., D'Incecco, P., Mora, D., Pinto, A., and Arioli, S. (2019). Antimicrobial activity of resveratrol-derived monomers and dimers against foodborne pathogens. Sci. Rep. 9: 19525.
Nikinmaa, M. (2014). Chapter 6 - Factors Affecting the Bioavailability of Chemicals. An Introduction to Aquatic Toxicology. Academic Press, Oxford, pp. 65–72.
Peng, M., Tabashsum, Z., Anderson, M., Truong, A., Houser, A.K., Padilla, J., Akmel, A., Bhatti, J., Rahaman, S.O., and Biswas, D. (2020). Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods. Compr. Rev. Food Sci. Food Saf. 19: 1908–1933.
Rotches-Ribalta, M., Urpi-Sarda, M., Llorach, R., Boto-Ordoñez, M., Jauregui, O., Chiva-Blanch, G., Perez-Garcia, L., Jaeger, W., Guillen, M., Corella, D., Tinahones, F.J., Estruch, R., and Andres-Lacueva, C. (2012). Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method. J. Chromatogr. A. 1265: 105–113.
Selby-Pham, S.N.B., Miller, R.B., Howell, K., Dunshea, F., and Bennett, L.E. (2017). Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine. Sci. Rep. 7: 1931.
Setoguchi, Y., Oritani, Y., Ito, R., Inagaki, H., Maruki-Uchida, H., Ichiyanagi, T., and Ito, T. (2014). Absorption and Metabolism of Piceatannol in Rats. J. Agric. Food Chem. 62: 2541–2548.
Simó, C., and García-Cañas, V. (2020). Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Food Funct. 11: 6745–6776.
Sreng, N., Champion, S., Martin, J.-C., Khelaifia, S., Christensen, J.E., Padmanabhan, R., Azalbert, V., Blasco-Baque, V., Loubieres, P., Pechere, L., Landrier, J.-F., Burcelin, R., and Sérée, E. (2019). Resveratrol-mediated glycemic regulation is blunted by curcumin and is associated to modulation of gut microbiota. J. Nutr. Biochem. 72: 108218.
Sung, M.M., Kim, T.T., Denou, E., Soltys, C.-L.M., Hamza, S.M., Byrne, N.J., Masson, G., Park, H., Wishart, D.S., Madsen, K.L., Schertzer, J.D., and Dyck, J.R.B. (2017). Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome. Diabetes. 66: 418.
Tung, Y.-C., Lin, Y.-H., Chen, H.-J., Chou, S.-C., Cheng, A.-C., Kalyanam, N., Ho, C.-T., and Pan, M.-H. (2016). Piceatannol Exerts Anti-Obesity Effects in C57BL/6 Mice through Modulating Adipogenic Proteins and Gut Microbiota. Molecules. 21: 1419.
Vestergaard, M., and Ingmer, H. (2019). Antibacterial and antifungal properties of resveratrol. Int. J. Antimicrob. Agents. 53: 716–723.
Wang, P., Wang, J., Li, D., Ke, W., Chen, F., and Hu, X. (2020). Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis. J. Nutr. Biochem. 81: 108363.
Yang, C., Deng, Q., Xu, J., Wang, X., Hu, C., Tang, H., and Huang, F. (2019). Sinapic acid and resveratrol alleviate oxidative stress with modulation of gut microbiota in high-fat diet-fed rats. Int. Food Res. J. 116: 1202–1211.
Yang, S.-C., Tseng, C.-H., Wang, P.-W., Lu, P.-L., Weng, Y.-H., Yen, F.-L., and Fang, J.-Y. (2017). Pterostilbene, a Methoxylated Resveratrol Derivative, Efficiently Eradicates Planktonic, Biofilm, and Intracellular MRSA by Topical Application. Front Microbiol. 8: 1103.
Yin, X., Liao, W., Li, Q., Zhang, H., Liu, Z., Zheng, X., Zheng, L., and Feng, X. (2020). Interactions between resveratrol and gut microbiota affect the development of hepatic steatosis: A fecal microbiota transplantation study in high-fat diet mice. J. Funct. Foods. 67: 103883.
Zheng, Y., Wu, W., Hu, G., Qiu, L., Meng, S., Song, C., Fan, L., Zhao, Z., Bing, X., and Chen, J. (2018). Gut microbiota analysis of juvenile genetically improved farmed tilapia (Oreochromis niloticus) by dietary supplementation of different resveratrol concentrations. Fish Shellfish Immunol. 77: 200–207.
京公网安备11010802044758号